Boris Bastian, MD, PhD

MC1R variants increase risk of melanomas harboring BRAF mutations. (18368129)

Fargnoli MC, Fargnoli MC, Pike K, Pfeiffer RM, Tsang S, Rozenblum E, Munroe DJ, Golubeva Y, Calista D, Seidenari S, Massi D, Carli P, Bauer J, Elder DE, Bastian BC, Peris K, Landi MT PMID: 18368129

Distribution and significance of occult intraepidermal tumor cells surrounding primary melanoma. (18323782)

North JP, Kageshita T, Pinkel D, LeBoit PE, Bastian BC PMID: 18323782

Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development. (18006687)

Delmas V, Beermann F, Martinozzi S, Carreira S, Ackermann J, Kumasaka M, Denat L, Goodall J, Luciani F, Viros A, Demirkan N, Bastian BC, Goding CR, Larue L PMID: 18006687

Constitutive activation of the phosphatidyl inositol 3 kinase signalling pathway in acral lentiginous melanoma. (17999703)

Muchemwa FC, Ma D, Inoue Y, Curtin JA, Bastian BC, Ihn H, Kageshita T PMID: 17999703

[DNA copy number changes in the diagnosis of melanocytic tumors]. (17882420)

Bauer J, Bastian BC PMID: 17882420

The prevalence and prognostic value of BRAF mutation in thyroid cancer. (17717450)

Kebebew E, Weng J, Bauer J, Ranvier G, Clark OH, Duh QY, Shibru D, Bastian B, Griffin A PMID: 17717450

Absence of PDGFRA mutations in primary melanoma. (17762857)

Curtin JA, Pinkel D, Bastian BC PMID: 17762857

Expanding the genetic spectrum of pigmentation. (18721233)

Bastian BC, Pinkel D PMID: 18721233

Lack of somatic alterations of MC1R in primary melanoma. (18761657)

Kim RD, Curtin JA, Bastian BC PMID: 18761657

Establishment of a novel melanoma cell line SMYM-PRGP showing cytogenetic and biological characteristics of the radial growth phase of acral melanomas. (17488338)

Murata H, Ashida A, Takata M, Yamaura M, Bastian BC, Saida T PMID: 17488338